NCT00000768View on ClinicalTrials.gov

A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

August 31, 1998

Conditions

ColitisHIV Infections

Interventions

DRUG

Glutamic acid hydrochloride

DRUG

Ganciclovir

Trial Locations (5)

10016

NY Univ. HIV/AIDS CRS, New York

35294

Alabama Therapeutics CRS, Birmingham

45267

Univ. of Cincinnati CRS, Cincinnati

Unknown

Ucsf Aids Crs, San Francisco

Washington U CRS, St Louis

All Listed Sponsors

collaborator

Hoffmann-La Roche

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000768 - A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients | Biotech Hunter | Biotech Hunter